TREATMENT OF ORGAN TRANSPLANT–RELATED LYMPHOMA

This publication has 32 references indexed in Scilit:

• Posttransplantation Lymphoproliferative Disorder in Patients Under Primary Tacrolimus (FK 506) Immunosuppression
  JAMA Otolaryngology–Head & Neck Surgery, 1995
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
  Blood, 1995
• Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders
  Blood, 1993
• Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
  New England Journal of Medicine, 1991
• CONFIRMATION OF THE HETEROGENEITY OF CELL PROLIFERATIONS1 BY IMMUNOGLOBULIN GENE REARRANGEMENT ANALYSES POSTTRANSPLANT EPSTEIN-BARR VIRUS-ASSOCIATED B
  Transplantation, 1989
• THE FREQUENCY OF EPSTEIN-BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN
  Transplantation, 1988
• LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN THERAPY
  The Lancet, 1984
• Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant Recipients
  New England Journal of Medicine, 1984
• Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal Transplantation
  New England Journal of Medicine, 1982
• Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.
  Proceedings of the National Academy of Sciences, 1979